Gilles Erb

ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question—to treat or not to treat?

M. Dietel, F. López-Ríos, F. Barlesi, 2018, ESMO Open.

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma

Paul Hofman, Emmanuel Chamorey, Olivier Guérin, 2018, Cancers.

Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer.

P. Hofman, V. Hofman, Marame Hamila, 2018, Lung cancer.

Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking.

Jan-Eric Litton, Andres Metspalu, Helen M Moore, 2017, Biopreservation and biobanking.

Phase II study (KAMELEON) of single‐agent T‐DM1 in patients with HER2‐positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma

J. Tabernero, E. de Vries, L. Gianni, 2023, Cancer medicine.